The health care sector was a popular one in the third quarter for hedge fund managers looking for merger-arbitrage opportunities. Takeover targets like Kinetic Concepts, Cephalon and Medco Health Solutions (MHS) were snatched up during the quarter, increasing health care weightings for several hedge fund managers.
The merger activity is one way to explain the strong performance of the health care sector this year. Health care names in the S&P 500 are up 6.1% overall, according to Capital IQ, the second best sector performance this year. The outlook for health care stocks, though, leaves plenty to be desired. After notching only 7% earnings growth in the third quarter, analysts are only calling for 5% earnings growth for the sector in 2012. In addition, health care companies will be in limbo as President Obama's health care reform bill gets challenged in the courts.
If they weren't playing M&A activity in the sector, hedge fund managers were selling for the most part. Pfizer (PFE) was a popular name to sell, with David Tepper's Appaloosa Management and David Einhorn's Greenlight Capital reducing their holdings in the drugmaker. Tepper also sold shares of fellow drug stock Merck (MRK), as well as Medtronic (MDT) and UnitedHealth Group (UNH).Elsewhere, Steven Cohen's SAC Capital sold out of Dendreon (DNDN), which had been one of the hedge fund's largest holdings before the stock crumbled. Cohen's fund also sold shares of Tenet Healthcare (THC), Express Scripts (ESRX) and Novartis (NVS), among others. Meanwhile, both Blue Ridge Capital and Omega Advisors cut their holdings in Teva Pharmaceutical (TEVA), although that may be due to the fact that the company's shares fell very sharply in August.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV